Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations

This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.


Life Saving Drugs Program – Gaucher disease – Medicines review summary

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
General public

Help us improve

If you would like a response please use the enquiries form instead.